RecruitingNot ApplicableNCT05406063

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases a Multicentre Prospective, Open Label, Randomised Controlled Phase 3 Non-inferiority Clinical Trial

Sponsor

Kantonsspital Winterthur KSW

Enrollment

162 participants

Start Date

Jun 1, 2022

Study Type

INTERVENTIONAL

Conditions

Pain Bone Metastases Radiation Therapy

Summary

To investigate, whether multi-fraction stereotactic body radiation therapy (SBRT) within 3 treatment fractions is non-inferior to the current standard of care of 5 fraction SBRT regarding pain response at 3 months after radiotherapy.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying SBRT for people with bone metastases, pain, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONSBRT

Stereotactic multiple fraction radiotherapy

Locations(2)

Kantonsspital Winterthur

Winterthur, Canton of Zurich, Switzerland

University Hospital Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05406063

Related Trials

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

NCT01719055118 locations

A Randomized Controlled Trial to Assess the Impact of Live and Recorded Music-Based Interventions on Pre-operative Stress, Mood, Pain and Biomarkers, in Neurosurgical Patients (Music-STAR Trial)

NCT065365041 location